Arkolith/Insider Trading/LENZ/Form 4

Olsson Shawn

Chief Commercial OfficerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Apr 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2025Option exercise(M)1K$2.08$3K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 9, 2025Option exercise(M)1K—$063K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001815776-25-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML